Literature DB >> 21525301

Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Mads Breum Larsen1, Mark S Sonders, Ole Valente Mortensen, Gaynor A Larson, Nancy R Zahniser, Susan G Amara.   

Abstract

The serotonin transporter (SERT) is the principal mechanism for terminating serotonin (5-HT) signals in the nervous system and is a site of action for a variety of psychoactive drugs including antidepressants, amphetamines, and cocaine. Here we show that human SERTs (hSERTs) and rat SERTs are capable of robust dopamine (DA) uptake through a process that differs mechanistically from 5-HT transport in several unanticipated ways. DA transport by hSERT has a higher maximum velocity than 5-HT transport, requires significantly higher Na(+) and Cl(-) concentrations to sustain transport, is inhibited noncompetitively by 5-HT, and is more sensitive to SERT inhibitors, including selective serotonin reuptake inhibitors. We use a thiol-reactive methane thiosulfonate (MTS) reagent to modify a conformationally sensitive cysteine residue to demonstrate that hSERT spends more time in an outward facing conformation when transporting DA than when transporting 5-HT. Cotransfection of an inactive or an MTS-sensitive SERT with wild-type SERT subunits reveals an absence of cooperative interactions between subunits during DA but not 5-HT transport. To establish the physiological relevance of this mechanism for DA clearance, we show using in vivo high-speed chronoamperometry that SERT has the capacity to clear extracellularly applied DA in the hippocampal CA3 region of anesthetized rats. Together, these observations suggest the possibility that SERT serves as a DA transporter in vivo and highlight the idea that there can be distinct modes of transport of alternative physiological substrates by SERT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525301      PMCID: PMC3107525          DOI: 10.1523/JNEUROSCI.0576-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.

Authors:  S Schroeter; S Apparsundaram; R G Wiley; L H Miner; S R Sesack; R D Blakely
Journal:  J Comp Neurol       Date:  2000-05-01       Impact factor: 3.215

Review 2.  Long distance signalling in volume transmission. Focus on clearance mechanisms.

Authors:  A Jansson; A Lippoldt; T Mazel; T Bartfai; S O Ogren; E Syková; L F Agnati; K Fuxe
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

3.  Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum.

Authors:  Elisa Mengual; Virginia M Pickel
Journal:  Synapse       Date:  2002-03-01       Impact factor: 2.562

4.  Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate.

Authors:  Joel W Schwartz; Randy D Blakely; Louis J DeFelice
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

5.  Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.

Authors:  I Sora; F S Hall; A M Andrews; M Itokawa; X F Li; H B Wei; C Wichems; K P Lesch; D L Murphy; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

6.  Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.

Authors:  A J Azzaro; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1973-11-15       Impact factor: 5.858

7.  Differential polarization of serotonin transporters in axons versus soma-dendrites: an immunogold electron microscopy study.

Authors:  J H Tao-Cheng; F C Zhou
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

8.  Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.

Authors:  Feng C Zhou; Klaus-Peter Lesch; Dennis L Murphy
Journal:  Brain Res       Date:  2002-06-28       Impact factor: 3.252

9.  Structural analysis of the extracellular entrance to the serotonin transporter permeation pathway.

Authors:  Melissa I Torres-Altoro; Charles P Kuntz; David E Nichols; Eric L Barker
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

10.  Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.

Authors:  Shannon N Saldaña; Eric L Barker
Journal:  Neurosci Lett       Date:  2004-01-16       Impact factor: 3.046

View more
  46 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 2.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

3.  Substrate-induced unlocking of the inner gate determines the catalytic efficiency of a neurotransmitter:sodium symporter.

Authors:  Christian B Billesbølle; Mie B Krüger; Lei Shi; Matthias Quick; Zheng Li; Sebastian Stolzenberg; Julie Kniazeff; Kamil Gotfryd; Jonas S Mortensen; Jonathan A Javitch; Harel Weinstein; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

Review 4.  Presynaptic effects of levodopa and their possible role in dyskinesia.

Authors:  Eugene V Mosharov; Anders Borgkvist; David Sulzer
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

5.  Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.

Authors:  Aram B Cholanians; Andy V Phan; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

Review 6.  Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Authors:  S Navailles; M Lagière; A Contini; P De Deurwaerdère
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

7.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

8.  Functional properties of dopamine transporter oligomers after copper linking.

Authors:  Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-12-21       Impact factor: 5.372

Review 9.  Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Authors:  Kathryn Lanza; Christopher Bishop
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

10.  Comparative modeling of the human monoamine transporters: similarities in substrate binding.

Authors:  Heidi Koldsø; Anja B Christiansen; Steffen Sinning; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.